Product NDC: | 99207-500 |
Proprietary Name: | Dysport |
Non Proprietary Name: | botulinum toxin type a |
Active Ingredient(s): | 300 [USP'U]/1 & nbsp; botulinum toxin type a |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 99207-500 |
Labeler Name: | Medicis Pharmaceutical Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA125274 |
Marketing Category: | BLA |
Start Marketing Date: | 20090525 |
Package NDC: | 99207-500-01 |
Package Description: | 1 VIAL in 1 CARTON (99207-500-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
NDC Code | 99207-500-01 |
Proprietary Name | Dysport |
Package Description | 1 VIAL in 1 CARTON (99207-500-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
Product NDC | 99207-500 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | botulinum toxin type a |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20090525 |
Marketing Category Name | BLA |
Labeler Name | Medicis Pharmaceutical Corp |
Substance Name | BOTULINUM TOXIN TYPE A |
Strength Number | 300 |
Strength Unit | [USP'U]/1 |
Pharmaceutical Classes | Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA] |